Quick Answer
Cellectis S.A. reported Total Assets of $324.72 million for fiscal year 2025.
Cellectis S.A. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $324.72M -15.3% |
$383.54M +68.5% |
$227.67M -12.8% |
$261.22M -31.6% |
$382.08M -18.6% |
$469.47M +0.4% |
| R&D Expense | $93.52M +3.3% |
$90.54M +3.3% |
$87.65M -10.1% |
$97.50M -17.3% |
$117.84M +52.9% |
$77.05M -16.3% |
- Cellectis S.A. reported Total Assets of $324.72 million for fiscal year 2025.
- Cellectis S.A. showed a decrease of -15.3% in Total Assets compared to the prior fiscal year.
- Cellectis S.A. reported R&D Expense of $93.52 million for fiscal year 2025.
- Cellectis S.A. showed an increase of +3.3% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: